India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
Did you know that one district in Uttar Pradesh is famous for its advanced hospitals…
Did you know that there was a time when girls in India were not allowed…
At India AI Impact Summit 2026, the Gujarat government signed a Memorandum of Understanding (MoU)…
Union Health Minister Jagat Prakash Nadda launched the indigenously manufactured Tetanus and Adult Diphtheria (Td)…
Did you know that one small island became famous across the world because of a…
Indian Railways has integrated Artificial Intelligence (AI) into seven key passenger-facing applications to improve grievance…